Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Nom du journal : Lancet Oncol

Année : 2018

Volume : 19

Page de départ : 747

Page de fin : 757

Auteurs: Hofmann WK, Fabarius A, Pfirrmann M, Janssen JJWM, Berger MG, Mustjoki S, Hjorth-Hansen H, Richter J, Saußele S, Martinez-Lopez J, Mayer J, Ehrencrona H, Rousselot P, Guilhot J, Hochhaus A, Mahon FX, Gruber FX, Almeida A, Koskenvesa P, Panayiotidis P, Olsson-Stromberg U, Vestergaard H, Kairisto V, Machova PK, Muller MC, on behalf of the EURO-SKI investigators,